Setmelanotide-mediated MC4R activation improves hypothalamic obesity via CaMKK2/AMPK pathways

Hypothalamic obesity (HO) is a disabling disease caused by central nervous system (CNS) damage due to neurosurgery, trauma, or tumors, especially in hypothalamus. The pathological mechanism of its neural circuits is still unclear, and there is currently no corresponding drug due to the complex etiol...

全面介紹

書目詳細資料

Principais autores:	Junjie Peng, Yichao Ou, Mingfeng Zhou, Xingqin Wang, Xi’an Zhang, Hao Long, Guangsen Wu, Mengjie Che, Kai Li, Le Yang, Zhu Zhang, Ken Kin Lam Yung, Songtao Qi, Zhanpeng Feng
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2026-01-01
叢編:	Frontiers in Pharmacology
主題:	CaMKK2/AMPK signaling GPCRs hypothalamic obesity melanocortin 4 receptor neuropharmacology setmelanotide
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1730786/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!